Search CROs

The supplied excerpts describe Pharma Tech Outlook, a print and digital publication covering pharmaceutical technology. They do not describe PPC Group or any contract research, development, or manufacturing services.

• Analytical Method Development & Validation
• Bioanalysis
• Clinical Operations

Veeda Lifesciences is a contract research organization offering preclinical R&D, BA/BE and bioanalytical studies, and Phase I–IV clinical trials for innovative, biosimilar, and generic drugs. Its capabilities cover both small and large molecules, including clinical bioanalysis and real-world evidence.

• Clinical Imaging Core Lab
• In Vivo Efficacy Models
• In Vivo PK / PD Studies

Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.

• Clinical Operations
• Clinical Trial Services

Care Access runs health screenings and connects volunteers to clinical trials, with site support staffing and referral services for research sites. It operates through country sites in the U.S., Canada, Poland, and Brazil.

• Biostatistics & Statistical Programming
• Clinical Operations
• Data Management & eClinical

Biometric CRO delivering clinical data management, biostatistics, statistical programming (SDTM/ADaM), and medical writing for biotech, pharma, and medtech sponsors. Offers a functional service provider model and the BioGRID trial analytics platform.

• Data Management & eClinical

Viedoc offers an EDC platform with ePRO, randomization, trial supply management, and medical coding modules for clinical trials. Its study build and study design review services are sold to CROs and sponsors.

• Clinical Operations
• Phase II Clinical Trials
• Phase III Clinical Trials

PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.

Japanese specialty chemicals manufacturer with product lines in consumer materials, construction materials, and environmental and water treatment. Excerpts show drug delivery system (DDS) material work with PURMX but no stated contract manufacturing or research services.

Roswell Park Comprehensive Cancer Center in Buffalo, NY is New York State's only National Cancer Institute-designated comprehensive cancer center outside NYC. Its excerpts describe patient cancer care, clinical trials, and research, but do not document GMP manufacturing or contract services for third parties.

• Analytical Method Development & Validation
• Bioanalysis
• Biomarker Assays

Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.

• Analytical Method Development & Validation
• Bioanalysis
• Genomics & Sequencing Services

Global bioanalytical CRO offering GLP-compliant assay development, validation, and testing for large-molecule biopharmaceuticals. Supports pre-clinical/CMC and clinical stages, including GMP-lot and market release testing.

• Analytical Method Development & Validation
• Biomarker Assays
• Immunogenicity Assays (ADA / NAb)

Sannova provides bioanalytical and analytical CRO services, including immunogenicity and ligand binding assays, PK testing, DMPK services, extractables and leachables, nitrosamine testing, and pharmaceutical stability testing. Its listed work spans small molecules, biologics and biosimilars, and cell and gene therapies.

• Bioanalysis
• Biostatistics & Statistical Programming
• Central Laboratory Services

ICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA.

• Bioanalysis
• Biostatistics & Statistical Programming
• Clinical Operations

Canadian CRO running early-phase clinical trials from a 24-bed Phase I unit, with in-house bioanalysis under a 21 CFR Part 11-compliant laboratory data management system. Its scientific affairs team supports protocol design, biostatistics, and submission-ready reports.

• Computational & In-Silico Drug Discovery
• Discovery Research
• In Vitro Pharmacology

Product development organization offering AI/ML-driven antibody and multispecific discovery, TCR mimic (TCRm) discovery, and antisense oligonucleotide design, backed by transgenic mouse platforms and pharmacology studies.

• Bioanalysis
• Phase I Clinical Trials
• Phase II Clinical Trials

Bioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.

• Antibody-Drug Conjugate (ADC)
• Biologics (Monoclonal Antibodies)

Boutique biologics CDMO with a Speed-to-Clinic platform spanning royalty-free cell line development through cGMP drug substance, in as little as 12 months. Runs a single-use mammalian GMP suite in Newton, MA for antibody, bispecific, and ADC programs.

• Discovery Research
• Preclinical In Vitro Studies
• Cell Therapy

Avigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.